2nd Annual Vaccines Congress
April 2, 2012 at 8:00 AM - April 3, 2012 at 5:00 PM
Radisson Blu Portman, London
This event requires registration: http://www.vaccines-congress.com
Oxford Global Conferences is proud to present its 2nd Annual Vaccines Congress 2012, which is to be held on the 2nd & 3rd April at the Radisson Blu Portman Hotel in London, UK. The congress is the single most focused event in Europe dedicated to assess key technological and scientific strategies in the pharmaceutical and biotech industry, as well as academic institutions in vaccines discovery and development. The vaccine market has become one of the largest growth areas in the healthcare industry and vaccines role in public health preparedness grows ever more with immunisation being one of the greatest achievements. This congress will provide up to date insights into the discovery and development of vaccine candidates for diseases. It will also cover current developments in Vaccine process development and production, new and novel technologies for Vaccines design, development and delivery, as well as implementation of successful clinical trials. Attendees at the event will benefit from strategies to lower cost and time to first dose, increase yield and optimise pipeline in Vaccines Discovery and Development.
Event Owner: Ross McIvor (Marketing Manager at Oxford Global Conferences)

Updates

Alex Kudrin MBBS MBA MD PhD MRCP ECPM MFPM (Medical Director in Gastroenterology, and Global Therapeutic Area Advisor in Immunology at TGRD) . Presentation on "Commercial, clinical and regulatory challenges in development of cancer vaccines: Opportunities and solutions"
Alex Kudrin MBBS MBA MD PhD MRCP ECPM MFPM (Medical Director in Gastroenterology, and Global Therapeutic Area Advisor in Immunology at TGRD) is attending.
Russell Golson (CEO at BioSilta Oy) will be attending.
Markus Ganzlin (Associate Principal Scientist in Cell Protein Structure Science (CPSS) at AstraZeneca) will be attending.
Lydia Millett (Events & Marketing Executive at Oxford Global) will be attending.
Malcolm Thomas (CEO at Arbovax,Inc) . Presenting on the development of Arbovax vaccines against Dengue and Chikungunya
Malcolm Thomas (CEO at Arbovax,Inc) will be attending.
Richard Boyd (CEO & Founder Incaplex) . I'm the CEO of 3Strata Technologies. We have developed a software application called Inca Clinic that manages vaccine schedules. While it is aimed heavily toward the management of travel related vaccines it is suitable for any type of vaccines schedule.
Dr Athanasios Papadopoulos (Global Clinical Research Physician - Senior Medical Advisor at Novartis) will be attending.
Dr Athanasios Papadopoulos (Global Clinical Research Physician - Senior Medical Advisor at Novartis) . I will be participating as a Speaker at the 2nd Annual Vaccines Congress, 2-3 April 2012 in London. I hope I will meet many of you there.
Show More...
Become a LinkedIn member. It's free!
Network with others attending this event
Attendees by company
Oxford Global
5
Takeda Pharmaceuticals
1
BioSilta
1
AstraZeneca
1
Arbovax,Inc
1